Form 8-K - Current report:
SEC Accession No. 0000950170-25-082494
Filing Date
2025-06-05
Accepted
2025-06-05 17:07:40
Documents
10
Period of Report
2025-06-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-20250604.htm   iXBRL 8-K 123420
  Complete submission text file 0000950170-25-082494.txt   239357

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT xene-20250604.xsd EX-101.SCH 30645
12 EXTRACTED XBRL INSTANCE DOCUMENT xene-20250604_htm.xml XML 4688
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 251028036
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)